Sentiment Trading

DaShenLin Pharmaceutical Group Co Ltd’s key shareholder, Ke Jinglong, plans to reduce his stake by up to 2% as part of a broader strategy to adjust the company’s asset structure.

DaShenLin Pharmaceutical Group Co., Ltd. is a prominent player in the pharmaceutical industry, with a diverse product range and strong market presence, positioning it for sustained growth and market expansion.